Abiopharma

Aurelion Reports Second Fiscal Quarter 2026 Financial Results

XCEL BRANDS announces sale of luxury fine jewelry brand Judith Ripka

Franklin Templeton Announces Availability of 19(a) Notices for Certain Closed-End Funds

BioReference® Launches BioReference Direct™, Expanding Access to Consumer-Initiated Diagnostic Testing Through a Fully Integrated Digital Platform

DoorDash Expands DashPass Beyond Delivery in Canada with Lyft Partnership

GrowGeneration Announces First Quarter 2026 Earnings Release Conference Call for May 12, 2026

Hadron Energy Secures U.S. Uranium Conversion Agreement with ConverDyn, Locking In Domestic Fuel Supply for the Halo Micro-Modular Reactor

Ceased to serve as a director - Ariel Rotter as of 1.5.26

Emergent BioSolutions Receives Approval from Singapore Health Sciences Authority for Expanded Indication of ACAM2000® (Smallpox and Mpox (Vaccinia) Vaccine, Live) to Include Mpox

MoneyHero Group Reports Unaudited Fourth Quarter and Audited Full Year 2025 Results